Table 2.
Characteristic | SLE Patients | Controls | p |
---|---|---|---|
No. | 163 | 160 | ND |
Age, yrs, mean ± SD | 43.3 ± 11.0 | 43.5 ± 10.5 | 0.90 |
Race, % (n) | |||
African American | 50.3 (82) | 50.6 (81) | 1.00 |
Caucasian | 39.3 (64) | 39.4 (63) | |
Asian | 4.9 (8) | 5.0 (8) | |
Hispanic | 4.3 (7) | 3.8 (6) | |
Other | 1.2 (2) | 1.2 (2) | |
CAC, median (IQR) | 0 (0–7.2) | 0 (0–0) | 0.0003 |
Homocysteine, μmol/l, mean ± SD (n) | 10.4 ± 1.4 | 9.2 ± 1.4 | < 0.0001 |
African American* | 12.1 ± 1.4 (82) | 9.7 ± 1.3 (81) | < 0.0001 |
Caucasian | 10.0 ± 1.3 (64) | 9.0 ± 1.5 (63) | 0.12 |
Framingham point scores, median (IQR) (n) | 8 (3–13) (161) | 8 (2–12) (156) | 0.39 |
GFR, ml/min/1.73m2, mean ± SD | 90.0 ± 32.5 | 94.5 ± 20.8 | 0.14 |
CAC: coronary artery calcification; GFR: glomerular filtration rate. ND: not determined; IQR: interquartile range.
African American case vs Caucasian case, p = 0.0009; African American control vs Caucasian control, p = 0.21.